Your browser doesn't support javascript.
loading
Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugate.
Funasaki, Shintaro; Mehanna, Sally; Ma, Wenjuan; Nishizawa, Hidekazu; Kamikubo, Yasuhiko; Sugiyama, Hiroshi; Ikeda, Shuji; Motoshima, Takanobu; Hasumi, Hisashi; Linehan, W Marston; Schmidt, Laura S; Ricketts, Chris; Suda, Toshio; Oike, Yuichi; Kamba, Tomomi; Baba, Masaya.
Afiliación
  • Funasaki S; Laboratory of Cancer Metabolism, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan.
  • Mehanna S; Laboratory of Cancer Metabolism, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan.
  • Ma W; Laboratory of Cancer Metabolism, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan.
  • Nishizawa H; Laboratory of Cancer Metabolism, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan.
  • Kamikubo Y; Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Sugiyama H; Department of Human Health Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ikeda S; Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan.
  • Motoshima T; Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, Japan.
  • Hasumi H; Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Linehan WM; Department of Urology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
  • Schmidt LS; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Ricketts C; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Suda T; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
  • Oike Y; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Kamba T; Laboratory of Stem Cell Regulation, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan.
  • Baba M; Cancer Science Institute of Singapore, Centre for Translational Medicine, National University of Singapore, Singapore City, Singapore.
Cancer Sci ; 113(7): 2352-2367, 2022 Jul.
Article en En | MEDLINE | ID: mdl-35396773
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido